Bicycle therapeutics to host r&d day on december 14

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq:bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that the company will host its first research and development (r&d) day on thursday, december 14. the event will take place in new york city from 8 a.m. to 12 p.m. eastern time and will be simultaneously webcast. bicycle therapeutics executives w.
BCYC Ratings Summary
BCYC Quant Ranking